Dr Michelle Tempest featured in the new Financial Times
4 December 2023Dr Michelle Tempest, Senior Partner at Candesic, featured in the Financial Times discussing the implications of increased reliance of the NHS on private providers. Private sector…Candesic Senior Partner Dr Michelle Tempest featured in the latest Healthcare Business International
28 November 2023Candesic Senior Partner Dr Michelle Tempest discusses in Healthcare Business International the constraints for the NHS to deliver on its targets. The financial pressure on the NHS makes outsourcing…Dr Michelle Tempest quoted in The Guardian
6 November 2023Candesic Senior Partner Dr Michelle Tempest contributed her perspective to The Guardian on Daye’s innovative STI diagnostic tampon which allows convenient testing at-home. The British start-up's innovative…HealthInvestor speaks to Dr Michelle Tempest about new Government AI fund
2 November 2023HealthInvestor features Dr Michelle Tempest, Senior Partner at Candesic, commenting on the government’s AI Life Sciences Accelerator Mission £100 million fund. The fund will…Candesic’s continued work in healthcare AI is aligned with new Government initiatives
1 November 2023Government initiatives such as the £100m investment programme to accelerate use of AI in life sciences, and the AI Safety…Dr Michelle Tempest quoted in the latest Financial Times
24 October 2023Senior partner at Candesic Dr Michelle Tempest shared in the Financial Times her views on the complex dynamics currently affecting the UK’s private healthcare sector. The recent…Candesic examines the phenomenon of synthetic human embryos
23 October 2023Dr Leonid Shapiro, managing partner at Candesic, and Dr Joe Taylor, principal at Candesic, examine the phenomenon of synthetic human…Electronic Health Records (EHR) in mental health: what’s next?
11 October 2023andesic team, Dr Michelle Tempest and Juliet Frances Thornton in the new LaingBuisson HealthcareMarkets UK investigate the opportunities of electronic…Business Analyst class of 2023
21 September 2023We are thrilled to introduce to you our Business Analyst class of 2023. Let`s welcome Jawad Barbar, Campbell Foubister, Zeynep…Candesic`s Dr Joe Taylor and Dr Leonid Shapiro published in the latest PharmaTimes
20 September 2023Candesic`s Dr Joe Taylor and Dr Leonid Shapiro discuss in PharmaTimes the significant opportunities, and the challenges, in the use…